Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;286(24):4852-4860.
doi: 10.1111/febs.15115. Epub 2019 Nov 18.

New views into class B GPCRs from the crystal structure of PTH1R

Affiliations
Free article
Review

New views into class B GPCRs from the crystal structure of PTH1R

Janosch Ehrenmann et al. FEBS J. 2019 Dec.
Free article

Abstract

The parathyroid hormone 1 receptor (PTH1R) is a major regulator of mineral ion homeostasis and bone metabolism and is thus considered an attractive drug target for the treatment of disorders in calcium metabolism and bone-related diseases such as osteoporosis. PTH1R is a member of the class B of GPCRs, which all share a dynamic multidomain binding mechanism to the peptide hormone. For a long time, these complexes have been recalcitrant to structural studies despite their great therapeutic relevance. Through extensive engineering of both the receptor and the peptide agonist ligand, we were able to determine the first high-resolution structure of a PTH1R-agonist complex. Comparisons of the PTH1R crystal structure with subsequently reported cryo-electron microscopy structures of the same receptor in complex with a G protein, as well as with other class B GPCR structures bound to antagonists, reveal new insights into the two-step activation mechanism of class B GPCRs and extend our understanding of the precise molecular rearrangements during receptor activation.

Keywords: G protein-coupled receptor; crystal structure; osteoporosis; parathyroid hormone 1 receptor; protein engineering.

PubMed Disclaimer

References

    1. Vilardaga JP, Romero G, Friedman PA & Gardella TJ (2011) Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm. Cell Mol Life Sci 68, 1-13.
    1. Stewart AF (2005) Hypercalcemia associated with cancer. N Engl J Med 352, 373-379.
    1. Selye H (1932) On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol. Endocrinology 16, 547-558.
    1. Pratley R, Amod A, Hoff ST, Kadowaki T, Lingvay I, Nauck M, Pedersen KB, Saugstrup T & Meier JJ (2019) Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet 394, 39-50.
    1. Pal K, Melcher K & Xu HE (2012) Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Acta Pharmacol Sin 33, 300-311.

Publication types

MeSH terms

Substances

LinkOut - more resources